Introduction
Viruses have become more prevalent today and may have existed from the beginning of time.2 Additionally, it poses a serious and dynamic threat due to its quick generation rates and clumsy replicating methods, which encourage fast evolution and can lead to enhanced virulence or the capacity to traverse species borders with disastrous results.
What is a virus?
Viruses are parasites that live inside host cells. To create a progeny virus, viruses need to enter the host's intended target cells and take control of the host's cellular machinery. The term "virus life cycle" refers to the series of events that take place during the different stages of virus multiplication that occur inside host cells. The virus replicates its genome, assembles the viral components, sheds its capsid, transcribes its RNA, translates it to viral proteins, enters the cell, localizes itself in the intracellular environment, and then leaves the cell.3
Steps in virus life cycle
Three steps comprise the life cycle of a virus: entry, genome replication, and exit. A businessman's life can be compared to the life cycle of a virus, with the entry being his route to work, the genome replication representing his task at work, and the exit representing his route home. Entry is the first step.3 The three stages of entry are attachment, penetration, and uncoating. During attachment, a virus particle enters the host cell and adheres to the cell surface. During uncoating, the virus loses its capsid. After uncoating, gene expression and viral genome replication use the exposed viral genome.
Following the accumulation of viral proteins and genomes, a progeny virion particle is formed and discharged extracellularly. The assembly of the virion and the cell's release make up the exit.
Transmission
There are two basic ways that viruses can spread: either by direct cell-to-cell contact or by diffusion across the extracellular space.4,5 Each of the viral propagation techniques has benefits and drawbacks. Cell-to-cell connections are not a barrier to the propagation of cell-free viruses, which can also more easily infect new hosts and travel large distances within infected hosts. Conversely, the ability to spread using cell-to-cell transmission to adjacent cells can be remarkably effective, and the utilisation of pre-existing cell-cell contacts can offer an additional means of spreading inside an organism. Since each method of transmission has benefits and drawbacks, viruses have developed mechanisms to utilise one or both of these channels. The vaccinia virus, for instance, produces several infectious particles.6 Mature viruses (MVs) are created when infected cells lyse and have the potential to promote host-to-host transmission through a cell-free channel. Conversely, an extracellular virus (EV) encased in two membranes and spreads from cell to cell remains attached to the surface of the cell that is creating it.
Portals of virus entry
A virus needs susceptible and permissive host cells in order to initiate infection. Various viruses use multiple different portals of entry. The majority of viruses interact with the layers of cells that line the body's interior cavities and exterior, known as the host epithelium.7 The primary partition separating the body's internal environment from the external environment is the epithelium. Mucosal epithelium covers all internal body surfaces, including the vaginal, gastrointestinal, and respiratory tracts. The epithelium is named for its mucus-covered protective layer.
Viruses are transferred to internal places by means of skin penetration—such as occurs after an animal or insect bite—or by transplanting an organ that is virally infected, the epithelium can be circumvented.8 Numerous viruses can potentially infect a foetus during or after pregnancy or passes through the placenta to reach a newborn.
The effects of the infection on the host cell can vary depending on the type of virus:
- It dies and is eliminated
- it endures, chronically (persistently) infects and constantly produces a few viruses
- it makes it through, and the virus's genome stays dormant, without generating any infectious particles
- it becomes immortalized and can divide into an infinite number of cells, a process that may lead to its malignant transformation into a cancer cell
Classification of viruses
Morphology
The size, shape, chemical makeup, genome structure, and replication mechanism of viruses are used to categorise them. Nucleocapsids of numerous filamentous and pleomorphic viruses have helical shape.9 A helical array of capsid proteins (protomers) encircling a helical filament of nucleic acid is what makes up helical nucleocapsids. Numerous "spherical" viruses' nucleocapsids have an icosahedral shape. For identification and categorization, the number and arrangement of the capsomeres—the morphologic subunits of the icosahedron—are important. An outer envelope is also present in many viruses.
Chemical make-up and replication mechanism
A virus's genome can be made up of either DNA or RNA, which can be linear or circular, single- or double-stranded (ds). A multipartite genome is made up of many nucleic acid segments, whereas a monopartite genome is made up of just one nucleic acid molecule. Different replication techniques are required for the various types of genomes.
Nomenclature
In addition to physical information, the categorization and naming of viruses take into account factors such as genome structure, replication mechanism, chemical makeup and arrangement of the nucleic acid, and whether the genome is multipartite or monopartite.9 When a complementary strand produced by a viral RNA transcriptase functions as mRNA, the genomic RNA strand of single-stranded RNA viruses is referred to as antisense (negative sense, minus sense) in orientation. Otherwise, it is known as sense (positive sense, plus sense) in orientation. The location of capsid assembly and the site of envelopment are also taken into account when classifying viruses especially in enveloped viruses.
Complications of viral infection
A meningoencephalitis, in which either encephalitis or meningitis may prevail, is usually the result of viruses invading the central nervous system (CNS). Additionally, viruses can damage spinal or brain blood arteries, resulting in ischemia.10 Encephalomyelitis, transverse myelitis, damage to peripheral nerves, or optic neuritis can arise from systemic or central nervous system infection by viruses or other infectious agents. This can cause a host immune response that cross-reacts with components of neural tissue.
The pathophysiology of atherosclerosis has been linked to several risk factors. Atherosclerotic disorders have been linked to certain viruses, and infectious diseases are thought to be a contributing cause.11 There are two theories on the contribution of viral infections to atherogenesis: direct and indirect effects. Atherosclerosis can be caused by viruses in two separate ways. By first infecting vascular cells, they can directly affect atherogenesis by causing inflammation in smooth muscle cells and endothelium. By infecting non-vascular cells and causing systemic inflammation, they can potentially have indirect consequences.
Numerous viruses specifically target the respiratory system in humans, resulting in a range of clinical symptoms from minor involvement of upper airways to life-threatening acute respiratory distress syndrome (ARDS).12
All ocular tissues may be affected by viral infections, which can have both immediate and long-term vision-threatening effects. Herpesvirus-induced ocular infections are the most common among them.13 The most common causes of infectious blindness in the West is HSV-1 keratitis and kerato-uveitis, primarily due to corneal opacification brought on by recurrences. They might therefore justify ongoing antiviral prophylaxis. Ten to twenty percent of shingles cases are caused by herpes zoster ophthalmicus, causing serious ocular involvement (keratitis, kerato-uveitis), of which one-quarter become chronic or recurring.
Trigeminal neuralgias following herpetic neuralgias can be especially severe. Although necrotizing retinitis brought on by herpesviruses (such as HSV, VZV, or CMV) is uncommon, it still needs to be treated as an acute visual emergency and calls for immediate intravenous and intravitreal antiviral therapy.14
Human oncoviruses cause a wide variety of cancer forms, and the percentage of each type of cancer linked to a viral infection varies greatly.15 Certain anogenital carcinomas, such as cervical, anal, vulvar, vaginal, and vulvar, HPVs typically infect stratified epithelium and cause carcinomas of other mucosal epithelium, especially oropharyngeal. Cervical carcinomas have a nearly 100% attributable fraction, whereas oral cavity and laryngeal malignancies have 4%. It's interesting to note that Western Europe and North America seem to be seeing a significant rise in the prevalence of HPV-associated oropharyngeal malignancies, especially in men.
Together, HBV and HCV cause three-quarters of hepatocellular carcinomas and have a tight tropism for hepatocytes.16 About half of Hodgkin's and Burkitt's lymphomas are caused by EBV, which typically infects B lymphocytes and epithelial cells.17,18 It is also an etiologic factor mostly of nasopharyngeal cancer cases. Furthermore, ~9% of these tumours have EBV-associated stomach cancer, a unique clinicopathological entity.19
Virtually, all Kaposi’s sarcomas are associated with KSHV infection. KSHV is also strongly associated with multicentric Castleman’s disease and primary effusion lymphoma, two relatively rare B-cell neoplasms.20 HTLV-1 infects lymphocytes and is a central cause of adult T-cell leukemia and lymphoma.21 MCPyV is commonly detected in normal skin and is responsible for approximately three-quarters of Merkel cell carcinoma, an uncommon skin cancer.22
Summary
Viral infections are not just short-term illnesses; they can lead to severe and long-lasting complications affecting multiple body systems. From neurological disorders like encephalitis and trigeminal neuralgia to life-threatening conditions such as acute respiratory distress syndrome (ARDS) and atherosclerosis, viruses can trigger significant health crises. Additionally, some viruses, including HPV, HBV, HCV, and EBV, are directly linked to the development of various cancers, highlighting their role in chronic disease progression. The ability of viruses to rapidly evolve, cross species barriers, and develop resistance to treatments underscores the urgent need for continued research, advanced antiviral therapies, and robust public health strategies. Strengthening global efforts in vaccination, early detection, and infection control remains crucial to mitigating the devastating impact of viral diseases on individuals and societies.
References
- Villarreal LP. Are Viruses Alive? Scientific American [Internet]. 2004 [cited 2024 May 24]; 291(6):100–5. Available from: https://www.jstor.org/stable/26060805.
- Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, Jong MD de, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005; 353(13):1374–85.
- Ryu W-S. Virus Life Cycle. Molecular Virology of Human Pathogenic Viruses [Internet]. 2017 [cited 2024 May 24]; 31–45. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158286/.
- Marsh M, Helenius A. Virus Entry: Open Sesame. Cell [Internet]. 2006 [cited 2024 May 24]; 124(4):729–40. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0092867406001826.
- Yakimovich A, Gumpert H, Burckhardt CJ, Lütschg VA, Jurgeit A, Sbalzarini IF, et al. Cell-Free Transmission of Human Adenovirus by Passive Mass Transfer in Cell Culture Simulated in a Computer Model. J Virol [Internet]. 2012 [cited 2024 May 24]; 86(18):10123–37. Available from: https://journals.asm.org/doi/10.1128/JVI.01102-12.
- Smith GL, Murphy BJ, Law M. Vaccinia Virus Motility. Annu Rev Microbiol [Internet]. 2003 [cited 2024 May 24]; 57(1):323–42. Available from: https://www.annualreviews.org/doi/10.1146/annurev.micro.57.030502.091037.
- Louten J. Virus Transmission and Epidemiology. Essential Human Virology [Internet]. 2016 [cited 2024 May 24]; 71–92. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148619/.
- Modrow S, Falke D, Truyen U, Schätzl H. Viruses: Definition, Structure, Classification. Molecular Virology [Internet]. 2013 [cited 2024 May 24]; 17–30. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123905/.
- Gelderblom HR. Structure and Classification of Viruses. In: Baron S, editor. Medical Microbiology [Internet]. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996 [cited 2024 May 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK8174/.
- Greenlee JE. Nervous System Complications of Systemic Viral Infections. Aminoff’s Neurology and General Medicine [Internet]. 2014 [cited 2024 May 24]; 857–83. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173564/.
- Hemmat N, Ebadi A, Badalzadeh R, Memar MY, Baghi HB. Viral infection and atherosclerosis. Eur J Clin Microbiol Infect Dis [Internet]. 2018 [cited 2024 May 24]; 37(12):2225–33. Available from: http://link.springer.com/10.1007/s10096-018-3370-z.
- Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, et al. Viral Respiratory Pathogens and Lung Injury. Clin Microbiol Rev. 2021; 34(3):e00103-20.
- Devilliers M-J, Ben Hadj Salah W, Barreau E, Da Cunha E, M’Garrech M, Bénichou J, et al. Atteintes ophtalmologiques des infections virales. Rev Med Interne [Internet]. 2021 [cited 2024 May 24]; 42(6):401–10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646372/.
- Feller L, Khammissa RAG, Fourie J, Bouckaert M, Lemmer J. Postherpetic Neuralgia and Trigeminal Neuralgia. Pain Res Treat [Internet]. 2017 [cited 2024 May 24]; 2017:1681765. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735631/.
- Martel C de, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664–70.
- Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep. 2019; 6(2):104–11.
- Saha A, Robertson ES. Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus. J Virol. 2019; 93(13):e00238-19.
- Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64–80.
- Bae J-M, Kim EH. Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies. J Prev Med Public Health [Internet]. 2016 [cited 2024 May 24]; 49(2):97–107. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829373/.
- Katano H. Pathological Features of Kaposi’s Sarcoma-Associated Herpesvirus Infection. Adv Exp Med Biol. 2018; 1045:357–76.
- Tagaya Y, Matsuoka M, Gallo R. 40 years of the human T-cell leukemia virus: past, present, and future. F1000Res. 2019; 8:F1000 Faculty Rev-228.
- Kervarrec T, Samimi M, Guyétant S, Sarma B, Chéret J, Blanchard E, et al. Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review. Front Oncol. 2019; 9:451.

